DrugPatentWatch Database Preview
VIBATIV Drug Profile
When do Vibativ patents expire, and what generic alternatives are available?
Vibativ is a drug marketed by Theravance Biopharma and is included in one NDA. There are eleven patents protecting this drug.
The generic ingredient in VIBATIV is telavancin hydrochloride. Two suppliers are listed for this compound. Additional details are available on the telavancin hydrochloride profile page.
Summary for VIBATIV
| US Patents: | 11 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 4 |
| Clinical Trials: | 13 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for VIBATIV |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for VIBATIV |
| DailyMed Link: | VIBATIV at DailyMed |
Generic Entry Opportunity Date for VIBATIV
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for VIBATIV
| Ingredient-type | Lipoglycopeptides |
| Drug Class | Lipoglycopeptide Antibacterial |
Synonyms for VIBATIV
| 0701472ZG0 |
| 372151-71-8 |
| 560130-42-9 |
| AC1MIWRX |
| AM006875 |
| Arbelic |
| CHEBI:71226 |
| CHEBI:71229 |
| CHEMBL3301680 |
| CHEMBL507870 |
| D02IJB |
| D06057 |
| D0B9JO |
| DB06402 |
| HSDB 8194 |
| LS-192933 |
| N(3'')-[2-(decylamino)ethyl]-29-{[(phosphonomethyl)amino]methyl}vancomycin |
| SCHEMBL8287015 |
| SIB-1533A |
| T-1455 |
| Td 6424 |
| TD-6424 |
| Telavancin |
| Telavancin [INN] |
| Telavancin HCl |
| Telavancin Hydrochloride |
| Telavancin hydrochloride (USAN) |
| Telavancin hydrochloride [USAN] |
| Telavancin, Antibiotic for Culture Media Use Only |
| telavancina |
| telavancine |
| telavancinum |
| UNII-0701472ZG0 |
| UNII-XK134822Z0 |
| Vancomycin, N3'-(2-(decylamino)ethyl)-29-(((phosphonomethyl)amino)methyl)-, monohydrochloride |
| Vancomycin, N3''-(2-(decylamino)ethyl)-29-(((phosphonomethyl)amino)methyl)- |
| Vibativ (TN) |
| XK134822Z0 |
US Patents and Regulatory Information for VIBATIV
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Theravance Biopharma | VIBATIV | telavancin hydrochloride | POWDER;INTRAVENOUS | 022110-001 | Sep 11, 2009 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Theravance Biopharma | VIBATIV | telavancin hydrochloride | POWDER;INTRAVENOUS | 022110-002 | Sep 11, 2009 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Theravance Biopharma | VIBATIV | telavancin hydrochloride | POWDER;INTRAVENOUS | 022110-001 | Sep 11, 2009 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Theravance Biopharma | VIBATIV | telavancin hydrochloride | POWDER;INTRAVENOUS | 022110-001 | Sep 11, 2009 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Theravance Biopharma | VIBATIV | telavancin hydrochloride | POWDER;INTRAVENOUS | 022110-002 | Sep 11, 2009 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for VIBATIV
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Hungary | S1400024 | ➤ Sign Up |
| Luxembourg | 91908 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 0183521 | ➤ Sign Up |
| Japan | 2008231109 | ➤ Sign Up |
| Canada | 2726789 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for VIBATIV
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 7 | Finland | ➤ Sign Up | |
| 2012002 | Lithuania | ➤ Sign Up | PRODUCT NAME: TELAVANCINUM; REGISTRATION NO/DATE: EU/1/11/705/001, 2011 09 02 EU/1/11/705/002 20110902 |
| 2011100062 | Germany | ➤ Sign Up | PRODUCT NAME: TELAVANCIN ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ HIERVON, EINSCHLIESSLICH TELAVANCINHYDROCHLORID; REGISTRATION NO/DATE: EU/1/11/705/001-002 20110902 |
| 2012002,C1292612 | Lithuania | ➤ Sign Up | PRODUCT NAME: TELAVANCINUM; REGISTRATION NO/DATE: EU/1/11/705/001, 2011 09 02 EU/1/11/705/002 20110902 |
| 2011 00033 | Denmark | ➤ Sign Up | PRODUCT NAME: TELAVANCIN, ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER TELAVANCIN HYDROCHLORID |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
